<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01930695</url>
  </required_header>
  <id_info>
    <org_study_id>CR013</org_study_id>
    <nct_id>NCT01930695</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T</brief_title>
  <acronym>Pre-CRAFT</acronym>
  <official_title>Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Trial Unit, University Hospital Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to collect data of the performance and confirm the safety of the DX
      (Diagnostic eXtension) functionality in the Lumax 640/470 HF-T in patients with permanent
      atrial fibrillation and CRT-D indication according to current ESC guidelines. The DX
      functionality is a feature, which can be activated in the Lumax 640/740 HF-T when connected
      to the LinoxSMART S DX right ventricular lead. The combination of these devices enable atrial
      sensing via a sensing dipole in the ventricular lead and therefore reduces the number of
      implanted leads without sacrificing atrial information. Atrial pacing can not be provided but
      is not needed in patients with permanent atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of IEGM recording</measure>
    <time_frame>3 months</time_frame>
    <description>to assess if the IEGM Online recordings of the Lumax 640/740 HF-T with DX functionality provide adequate quality to classify the atrial rhythm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the Lumax 640/740 HF-T with DX functionality based on the Serious Adverse Device Effects related to the DX functionality</measure>
    <time_frame>3 months</time_frame>
    <description>to assess the safety of the Lumax 640/740 HF-T by the analysis of Serious Adverse Device Effects which are related to the DX functionality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the Lumax 640/740 HF-T with DX functionality based on all, serious and non-serious, Adverse Device Effects related to DX functionality</measure>
    <time_frame>3 months</time_frame>
    <description>to assess the safety of the Lumax 640/740 HF-T with DX functionality by the analysis of all (serious and non-serious) Adverse Device Effects which are related to the DX functionality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with maintenance of diagnosis of permanent AF</measure>
    <time_frame>3 months</time_frame>
    <description>to investigate whether the diagnosis of permanent AF at enrollment is maintained after device implantation</description>
  </primary_outcome>
  <enrollment type="Actual">18</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Failure patients with CRT-D indication according to current ESC guidelines and
        permanent atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CRT-D indication according to current ESC guidelines (NYHA III/IV; QRS≥120ms;
             LVEF≤35%; Expected survival ≥ 1 year; need for pacing because of slow ventricular rate
             or pacemaker dependency as a result of AV nodal ablation or ventricular rate ≤60bpm at
             rest and ≤90bpm on exercise)

          -  Permanent atrial fibrillation

          -  Patients planned to be implanted with BIOTRONIK Lumax 640/740 HF-T

          -  Patients planned to be implanted with BIOTRONIK LinoxSmart S DX right ventricular lead
             (or successors)

          -  Patient eligible for programming of DX functionality according to the physicians`
             decision

          -  Patient is willing and able to comply with the CIP and provided written informed
             consent

          -  Patient accepts Home Monitoring® concept and has sufficient GSM/GPRS coverage

        Exclusion Criteria:

          -  Patients with any contraindication to CRT-D therapy

          -  Patients listed for heart transplantation

          -  Life expectancy less than 12 months

          -  Pregnant or breast-feeding women

          -  Patients under the age of 18

          -  Patients with limited contractual capability

          -  Participation in any other clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Sticherling, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsspital Basel, Petersgraben 4, 4031 Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herz- und Gefäßzentrum Bad Bevensen</name>
      <address>
        <city>Bad Bevensen</city>
        <zip>29549</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marien-Hospital Lünen</name>
      <address>
        <city>Lünen</city>
        <zip>44534</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Mölln-Ratzeburg</name>
      <address>
        <city>Ratzeburg</city>
        <zip>23909</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Sticherling C, Müller D, Schaer BA, Krüger S, Kolb C; Pre-CRAFT investigators. Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy. Indian Pacing Electrophysiol J. 2018 Mar 27. pii: S0972-6292(17)30268-1. doi: 10.1016/j.ipej.2018.03.005. [Epub ahead of print]</citation>
    <PMID>29596906</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2013</study_first_submitted>
  <study_first_submitted_qc>August 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2013</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DX functionality</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>CRT-D indication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

